Renal amyloidosis in children

Pediatric Nephrology

Volumn 26, Issue 8, 2011, Pages 1215-1227

  Bilginer, Yelda ^a   Akpolat, Tekin ^b   Ozen, Seza ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b ONDOKUZ MAYIS UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Autoinflammatory diseases; Children; Renal amyloidosis

Indexed keywords

AMYLOID PROTEIN; ANTILIPEMIC AGENT; APOLIPOPROTEIN A; APOLIPOPROTEIN A2; BETA 2 MICROGLOBULIN; C REACTIVE PROTEIN; COLCHICINE; CORTICOSTEROID; CYSTATIN C; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPRODISATE; FIBRINOGEN; GELSOLIN; INTERLEUKIN 1 ANTIBODY; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIVER ENZYME; LYSOZYME; PREALBUMIN; PROTEIN; PROTEIN PRECURSOR; PYRIN PROTEIN; PYRINDAMYCIN A; SERUM AMYLOID A; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR INHIBITOR; UNCLASSIFIED DRUG;

ABDOMINAL FAT; ABDOMINAL PAIN; ADRENAL INSUFFICIENCY; ARTHRALGIA; ARTHROPATHY; AUTOINFLAMMATORY DISEASE; AUTONOMIC NEUROPATHY; BEHCET DISEASE; BETA 2 MICROGLOBULIN URINE LEVEL; BLEEDING TENDENCY; BLOOD CLOTTING FACTOR 10 DEFICIENCY; BONE CYST; BONE MARROW BIOPSY; CARPAL TUNNEL SYNDROME; CHILDHOOD DISEASE; CHRONIC GRANULOMATOUS DISEASE ASSOCIATED ASPERGILLOSIS; CINCA SYNDROME; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONJUNCTIVITIS; CONSTIPATION; CYTOKINE PRODUCTION; DIARRHEA; DIASTOLIC DYSFUNCTION; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DRUG MECHANISM; DRUG METABOLISM; DYSPEPSIA; EDEMA; EPISCLERITIS; ERYTHROCYTE SEDIMENTATION RATE; FAMILIAL MEDITERRANEAN FEVER; FEVER; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL OBSTRUCTION; GASTROINTESTINAL TRACT; GENE MUTATION; HEADACHE; HEART ARRHYTHMIA; HEMODIALYSIS; HEPATOMEGALY; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; HYPERSPLENISM; HYPOALBUMINEMIA; HYPOGONADISM; HYPOTHYROIDISM; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INCIDENCE; INFLAMMATION; JOINT SWELLING; JUVENILE RHEUMATOID ARTHRITIS; KIDNEY AMYLOIDOSIS; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MALABSORPTION; MALNUTRITION; MIXED HEARING LOSS; MUSCLE HYPERTROPHY; MYALGIA; NAUSEA; OPTIC NERVE; PAPILLITIS; PATHOGENESIS; PATHOLOGIC FRACTURE; PATHOPHYSIOLOGY; PERIORBITAL EDEMA; PERIPHERAL NEUROPATHY; PERITONEAL DIALYSIS; PLEURISY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN SYNTHESIS; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL (TOPIC); RASH; RECTUM BIOPSY; RENAL REPLACEMENT THERAPY; RESPIRATORY TRACT DISEASE; REVIEW; SICKLE CELL ANEMIA; SPLENOMEGALY; SPONDYLOARTHROPATHY; SYSTOLIC DYSFUNCTION; THROMBOSIS; TREATMENT CONTRAINDICATION; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PERIODIC SYNDROME; URTICARIA; UVEITIS; VASCULITIS;

AMYLOIDOSIS; CHILD; HEREDITARY AUTOINFLAMMATORY DISEASES; HUMANS; KIDNEY DISEASES;

EID: 80052461176     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-011-1797-x     Document Type: Review

References (111)

1. Perfetto F, Moggi-Pignone A, Livi R, Tempestini A, Bergesio F, Matucci-Cerinic M (2010) Systemic amyloidosis: a challenge for the rheumatologist. Nat Rev Rheumatol 6:417-429.
2. Röcken C, Shakespeare A (2002) Pathology, diagnosis and pathogenesis of AA amyloidosis. Virchows Arch 440:111-122. (Pubitemid 34169846)
3. Picken MM (2007) New insights into systemic amyloidosis: the importance of diagnosis of specific type. Curr Opin Nephrol Hypertens 16:196-203. (Pubitemid 46608527)
4. Rysavá R (2007) AL amyloidosis with renal involvement. Kidney Blood Press Res 30:359-364. (Pubitemid 350191433)
5. Drüeke TB, Massy ZA (2009) Beta2-microglobulin. Semin Dial 22:378-380.
6. Lachmann HJ, Booth DR, Booth SE, Bybee A, Gilbertson JA, Gillmore JD, Pepys MB, Hawkins PN (2002) Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis. N Engl J Med 6(346):1786-1791. (Pubitemid 34586914)
7. Westermark P, Bergström J, Solomon A, Murphy C, Sletten K (2003)Transthyretin-derived senile systemic amyloidosis: clinicopathologic and structural considerations. Amyloid 10 Suppl 1:48-54. (Pubitemid 37372567)
8. Ozen S (2004) Renal amyloidosis in familial Mediterranean fever. Kidney Int 65:1118-1127. (Pubitemid 38258281)
9. Falk RH, Comenzo RL, Skinner M (1997) The systemic amyloidoses. N Engl J Med 337:898-909. (Pubitemid 27408573)
10. Ben Chetritt R (2003) FMF and renal amyloidosis. Phenotypegenotype correlation, treatment and prognosis. J Nephrol 16:431-434.
11. Tunca M, Akar S, Onen F, Ozdogan H, Kasapcopur O, Yalcinkaya F, Tutar E, Ozen S, Topaloglu R, Yilmaz E, Arici N, Bakkaloglu A, Besbas N, Akpolat T, Dinc A, Erken E; Turkish FMF study group (2005) Familial Mediterranean fever in Turkey. Results of a nationwide multicenter study. Medicine 84:1-11.
12. Tuglular S, Yalcinkaya F, Paydas S, Oner A, Utas C, Bozfakioglu S, Ataman R, Akpolat T, Ok E, Sen S, Düsünsel R, Evrenkaya R, Akoglu E (2002) A retrospective analysis for aetiology and clinical findings of 287 secondary amyloidosis cases in Turkey. Nephrol Dial Transplant 17:2003-2005. (Pubitemid 35277102)
13. Uda H, Yokota A, Kobayashi K, Miyake T, Fushimi H, Maeda A, Saiki O (2006) Two distinct clinical courses of renal involvement in rheumatoid patients with AA amyloidosis. J Rheumatol 33:1482-1487. (Pubitemid 44168816)
14. Nishi S, Alchi B, Imai N, Gejyo F (2008) New advances in renal amyloidosis. Clin Exp Nephrol 12:93-101.
15. Neugarten J, Gallo GR, Buxbaum J, Katz LA, Rubenstein J, Baldwin DS (1986) Amyloidosis in subcutaneous heroin abusers ("skin poppers' amyloidosis"). Am J Med 81:635-640. (Pubitemid 17178143)
16. Orfila C, Lepert JC, Modesto A, Bernadet P, Suc JM (1991) Fanconi's syndrome, kappa light-chain myeloma, non-amyloid fibrils and cytoplasmic crystals in renal tubular epithelium. Am J Nephrol 11:345-349.
17. Dubrey SW, Cha K, Simms RW, Skinner M, Falk RH (1996) Electrocardiography and Doppler echocardiography in secondary (AA) amyloidosis. Am J Cardiol 77:313-315. (Pubitemid 26059307)
18. Dubrey SW, Cha K, Anderson J, Chamarthi B, Reisinger J, Skinner M, Falk RH (1998) The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement. QJM 91:141-157. (Pubitemid 28102667)
19. Benson MD (2003) The hereditary amyloidoses. Best Pract Res Clin Rheumatol 17:909-927. (Pubitemid 38324645)
20. Sattianayagam P, Hawkins P, Gillmore J (2009) Amyloid and the GI tract. Expert Rev Gastroenterol Hepatol 3:615-630.
21. Ebert EC, Nagar M (2008) Gastrointestinal manifestations of amyloidosis. Am J Gastroenterol 103:776-787. (Pubitemid 351405997)
22. Chopra S, Rubinow A, Koff RS, Cohen AS (1984) Hepatic amyloidosis. A histopathologic analysis of primary (AL) and secondary (AA) forms. Am J Pathol 115:186-193. (Pubitemid 14145900)
23. Looi LM, Sumithran E (1988) Morphologic differences in the pattern of liver infiltration between systemic AL and AA amyloidosis. Hum Pathol 19:732-735.
24. Renzulli P, Schoepfer A, Mueller E, Candinas D (2009) Atraumatic splenic rupture in amyloidosis. Amyloid 16:47-53.
25. Elvy A, Harbach L, Bhangu A (2010) Atraumatic splenic rupture: a 6-year case series. Eur J Emerg Med. doi:10.1097/MEJ.0b013e32833ddeb5.
26. Renzulli P, Schoepfer A, Mueller E, Candinas D (2009) Atraumatic splenic rupture in amyloidosis. Amyloid 16:47-53.
27. Sungur C, Sungur A, Ruacan S, Arik N, Yasavul U, Turgan C, Caglar S (1993) Diagnostic value of bone marrow biopsy in patients with renal disease secondary to familial Mediterranean fever. Kidney Int 44:834-836. (Pubitemid 23290525)
28. Sucker C, Hetzel GR, Grabensee B, Stockschlaeder M, Scharf RE (2006) Amyloidosis and bleeding: pathophysiology, diagnosis, and therapy. Am J Kidney Dis 47:947-955. (Pubitemid 43767332)
29. Zangari M, Elice F, Fink L, Tricot G (2007) Hemostatic dysfunction in paraproteinemias and amyloidosis. Semin Thromb Hemost 33:339-349. (Pubitemid 46878106)
30. Benson MD, Kincaid JC (2007) The molecular biology and clinical features of amyloid neuropathy. Muscle Nerve 36:411-423. (Pubitemid 47512065)
31. Keven K, Oztas E, Aksoy H, Duman N, Erbay B, Ertürk S (2001) Polyglandular endocrine failure in a patient with amyloidosis secondary to familial Mediterranean fever. Am J Kidney Dis 38:E39.
32. Herrera GA, Turbat-Herrera EA (2010) Renal diseases with organized deposits: an algorithmic approach to classification and clinicopathologic diagnosis. Arch Pathol Lab Med 134:512-531.
33. Sen S, Sarsik B (2010) A proposed histopathologic classification, scoring, and grading system for renal amyloidosis: standardization of renal amyloid biopsy report. Arch Pathol Lab Med 134:532-544.
34. Hawkins PN (2002) Serum amyloid P component scintigraphy for diagnosing and monitoring amyloidosis. Curr Opin Nephrol Hypertens 11:649-655. (Pubitemid 35440848)
35. Petty RE, Soutwood TR, Manners P, Baum J, Glass DN, Goldenberg J, He X, Maldonado-Cocco J, Orozco-Alcala J, Prieur A, Suarez Almazor ME, Woo P (2004) International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31:390-392. (Pubitemid 38160763)
36. Besbas N, Saatci U, Bakkaloǧlu A, Ozen S (1992) Amyloidosis of juvenile chronic arthritis in Turkish children. Scand J Rheumatol 21:257-259.
37. Stojanov S, Kastner DL (2005) Familial autoinflammatory diseases: genetics, pathogenesis and treatment. Curr Opin Rheumatol 17:586-599. (Pubitemid 41527820)
38. Masters SL, Simon A, Ksentijevic I, Kastner DL (2009) Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease. Annu Rev Immunol 27:621-628.
39. Ozen S, Karaaslan Y, Ozdemir O, Saatci U, Bakkaloglu A, Koroglu E, Tezcan S (1998) Prevalence of juvenile chronic arthritis and familial Mediterranean fever in Turkey. J Rheumatol 25:2445-2449. (Pubitemid 28551865)
40. Sohar E, Gafni J, Pras M, Heller H (1967) Familial Mediterranean fever. A survey of 470 cases and review of literature. Am J Med 43:227-253.
41. Majeed HA, El-Shanti H, Al-Khateeb MS, Rabia ZA (2002) Genotype/phenotype correlations in Arab patients with FMF. Semin Arthritis Rheum 31:371-376. (Pubitemid 34734376)
42. Chae JJ, Wood G, Richard K, Jaffe H, Colburn NT, Masters SL, Gumucio DL, Shoham NG, Kastner DL (2008) The familial Mediterranean fever protein, pyrin is cleaved by caspase-1 and activates NF-kappa B through its N-terminal fragment. Blood 11:1794-1803.
43. Samuels J, Ozen S (2006) Familial Mediterranean fever and the other auto inflammatory syndromes: evaluation of the patient with recurrent fever. Curr Opin Rheumatol 18:108-117. (Pubitemid 43740413)
44. International FMF Consortium (1997) Ancient missense mutations in a new number of the Roret gene family are likely to cause FMF. Cell 90:797-807.
45. French FMF consortium (1997) A candidate gene for familial Mediterranean fever. Nat Genet 17:25-31.
46. Ozen S, Balci B, Ozkara S, Ozcan A, Yilmaz E, Besbas N, Ozguc M, Kastner DL, Bakkaloglu A (2002) Is there a heterozygote advantage for familial Mediterranean fever carriers against tuberculous infections? Clin Exp Rheumatol 20:S57-S58.
47. Ozen S (2009) Mutations/polymorphisms in a monogenic auto inflammatory disease is a susceptibility marker for certain rheumatic diseases. Lessons from the bedside for the benchside. Curr Opin Rheumatol 27:S29-S31.
48. Booth DR, Lachman JJ, Gillmor JD, Booth SE, Hawkins PN (2002) Prevalence and significance of the familial Mediterranean gene mutation encoding pyrin Q148. QJM 95:332-333.
49. Touitou I, Sarkisian T, Medlej-Hashim M, Tunca M, Livneh A, Cattan D, Yalcinkaya F, Ozen S, Majeed H, Ozdogan H, Kastner D, Booth D, Ben-Chetrit E, Pugnere D, Michelon C, Seguret F, Gershoni-Baruch R (2007) Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever. Arthritis Rheum 56:1706-1712. (Pubitemid 46764102)
50. Ozen S, Aktay N, Lainka E, Duzova A, Bakkaloglu A, Kallinich T (2009) Disease severity in children and adolescents with familial Mediterranean fever: a comparative study to explore environmental effects on a monogenic disease. Ann Rheum Dis 68:246-248.
51. Ben Chetrit E, Levy M (1998) Familial Mediterranean fever. Lancet 351:659-664. (Pubitemid 28098460)
52. Lidar M, Livneh A (2007) Familial Mediterranean fever: clinical, molecular and management advances. Neth J Med 65:318-324. (Pubitemid 350011355)
53. Ozen S (2010) The "other" vasculitis syndromes and kidney involvement. Pediatr Nephrol 25:1633-1639.
54. Lachmann HJ, Sengul B, Yavuzsen TU, Booth DR, Booth SE, Bybee A, Gallimore JR, Soytürk M, Akar S, Tunca M, Hawkins PN (2006) Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology 45:746-750. (Pubitemid 43985345)
55. Zemer D, Pras M, Sohar E, et Modan M, Cabili S, Gafni J (1986) Colchicine in the prevention and treatment of amyloidosis of familial Mediterranean fever. N Engl J Med 314:1001-1005. (Pubitemid 16138694)
56. Saatci U, Ozen S, Ozdemir S, Bakkaloglu A, Besbas N, Topaloglu R, Arslan S (1997) FMF in children: report of a large series and discussions of the risk and prognostic factors of amyloidosis. Eur J Pediatr 156:619-623. (Pubitemid 27351849)
57. Sohar E, Gafni J, Pras M, Heller H (1967) Familial Mediterranean fever. A survey of 470 cases and review of literature. Am J Med 43:227-253.
58. Shohat M, Magal N, Shohat T, Chen X, Dagan T, Mimouni A, Danon Y, Laron R, Ogur G, Schlezinger M, Halpern GJ, Schwabe A, Kastner D, Rotter JI, Fischel-Ghodslan N (1999) Phenotype-genotype correlation in FMF: evidence for an association between M694V and amyloidosis. Eur J Hum Genet 7:287-292. (Pubitemid 29213734)
59. Cakar N, Yalcinkaya F, Ozkaya N, Tekin M, Akar N, Koçak H, Misirlioǧlu M, Akar E, Tümer N (2001) FMF associated amyloidosis in childhood. Clinical features, course and outcome. Clin Exp Rheumatol 19:S63-S67. (Pubitemid 33730232)
60. Cazeneuve C, Ajrapetyan H, Papin S, Rpudot-Thoraval F, Genevieve D, Mindjoyan E, Papazian M, Sarkisian A, Babloyan A, Boissier B, Duquesnay P, Kouyoumdjian JC, Girodon-Boulandet E, Grateau G, Sarkisian T, Amselem S (2000) Identification of MEFV independent modifying genetic factors for FMF. Am J Hum Genet 67:1136-1143.
61. Gershoni-Baruch R, Brik R, Zacks N, Shinawi M, Lidar M, Livneh A (2003) The contribution of genotypes at the MEFVand SAA1 loci to amyloidosis and disease severity in patients with FMF. Arthritis Rheum 48:1149-1155. (Pubitemid 36418258)
62. Ozen S, Ben-Chetrit E, Bakkaloglu A, Gur H, Tinaztepe K, Calguneri M, Turgan C, Turkman A, Akpolat I, Danaci M, Besbas N, Akpolat T (2001) Polyarteritis nodosa in patients with FMF: a concomitant disease or a feature of FMF? Semin Arthritis Rheum 30:281-287. (Pubitemid 32172733)
63. Goldinger SE (1972) Colchicine for familial Mediterranean fever. N Engl J Med 287:1302.
64. Kallinich T, Haffner D, Niehues T, Huss K, Lainka E, Neudorf U, Schaefer C, Stajanov S, Timmann C, Keitzer R, Ozdogan H, Ozen S (2007) Colchicine use in children and adolescents with familial Mediterranean fever: literature review and consensus statement. Pediatrics 119:e474-e483. (Pubitemid 46397797)
65. Oner A, Erdogan O, Demircin G, Bulbul M, Memis L (2003) Efficacy of colchicine therapy in amyloid nephropathy of familial Mediterranean fever. Pediatr Nephrol 18:521-526. (Pubitemid 36790091)
66. Livneh A, Zemer D, Langevitz P, Laor A, Sohar E, Pras M (1994) Colchicine treatment of AA amyloidosis of familial Mediterranean fever: an analysis of factors affecting outcome. Arthritis Rheum 37:1804-1811. (Pubitemid 24371884)
67. Schattner A (1991) Colchicine-expanding horizons. Postgrad Med J 67:223-226.
68. Bohle A, Wehrmann M, Fissele R, Gise HV, Mackensen-Haen S, Müller C (1993) The long-term prognosis of AA and alamyloidosis and the pathogenesis of chronic renal failure in renal amyloidosis. Pathol Res Pract 89:316-331. (Pubitemid 23155662)
69. Bauer EZ, Valle KJ (1982) Colchicine-induced modulation of collagenase in human skin fibroblast cultures. Stimulation enzyme synthesis normal cells. J Invest Dermatol 79:398- 402. (Pubitemid 13247342)
70. Montseny JJ, Meyrier A, Gherardi RK (1996) Colchicine toxicity in patients with chronic renal failure. Nephrol Dial Transplant 11:2055-2058. (Pubitemid 26345473)
71. Wallace SL, Singer JZ, Duncan GJ, Wigley FM, Kunel RW (1991) Renal function predicts colchicine toxicity: guidelines for the prophylactic use of colchicine in gout. J Rheumatol 18:264- 269.
72. Anderson-Haag T, Patel B (2003) Safety of colchicine in dialysis patients. Semin Dial 16:412-413. (Pubitemid 37347016)
73. Hoffmann HM, Mueller JL, Broide DH, Wanderer AA, Kolodner RD (2001) Mutation of a new gene encoding a putative pyrin like protein causes familial cold autoinflammatory syndrome and Muckle Wells syndrome. Nat Genet 29:301-305. (Pubitemid 33096455)
74. Feldmann J, Prieur AM, Quartier P, Berquin P, Certain S, Cortis E, Teilac-Hamel D, Fischer A, de Saint BG (2002) Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes. Am J Hum Genet 71:198- 203. (Pubitemid 34734724)
75. Hoffman HM, Wanderer AA, Broide DH (2001) Familial cold autoinflammatory syndrome: phenotype and genotype of an autosomal dominant periodic fever. J Allergy Clin Immunol 108:615-620. (Pubitemid 32978035)
76. Toker O, Hashkes PJ (2010) Critical appraisal of canakinumab in the treatment of adults and children with cryopyrin-associated periodic syndrome (CAPS). Biologics 25:131-138.
77. Hawkins PN, Lachmann HJ, Aganna E, McDermott MF (2004) Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra. Arthritis Rheum 50:607-612. (Pubitemid 38198844)
78. Lachmann HJ, Kone-Paut I, Kuemmerle-Deschner JB, Leslie KS, Hachulla E, Quartier P, Gitton X, Widmer A, Patel N, Hawkins PN (2009) Use of canakinumab in the cryopyrin associated periodic syndrome. N Engl J Med 360:2416- 2425.
79. Drenth JP, Cuisset L, Grateau G, Vasseur C, van de Velde-Visser SD, de Jong JG, Beckmann JS, van der Meer JW, Delpech M (1999) Mutations in the gene encoding mevolanate kinase cause hyper-IgD and periodic fever syndrome. Nat Genet 22:178-181. (Pubitemid 29264814)
80. Goldbach-Mansky R, Kastner DL (2009) Autoinflammation: the prominent role of IL-1 in monogenic autoinflammatory diseases and implications for common illnesses. J Allergy Clin Immunol 124:1141-1149.
81. McDermott MF, Aksentijevich I, Galon J, McDermott EM, Ogunkolade BW, Centola M, Mansfield E, Godina M, Karenko L, Petterson T, McCarthy J, Frucht DM, Aringer M, Torosyan Y, Teppo AM, Wilson M, Karaaslan HM, Wan Y, Todd I, Wood G, Schlimgen R, Kumarajeewa TR, Cooper SM, Vella JP, Amos EI, Mulley J, Quane KA, Mollay MG, Ranki A, Powell RJ, Hitman GA, Shea JJ O, Kastner DL (1999) Germline mutations in the extracellular domains of the 55-kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 97:133-144. (Pubitemid 29165896)
82. Hull KM, Drewe E, Aksentijevich I, Singh HK, Wong K, McDermott EM, Dean J, Powell RJ, Kastner DL (2002) The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an auto inflammatory disorder. Medicine 81:349- 368.
83. Aksentijevich I, Galon J, Soares M, Mansfield E, Hull K, Oh HH, Goldbach-Mansky R, Dean J, Athreya B, Regianato AJ, Henrickson M, Pons-Estel B, O'Shea JJ, Kastner DL (2001) The tumor necrosis factor receptor associated periodic syndrome: new mutations in TNFRSF1A, ancestral origins, genotypephenotype studies, and evidence for further heterogeneity of periodic fevers. Am J Hum Genet 69:301-314.
84. Reddy P, Slack JL, Davis R, Cerretti DP, Kozlosky CJ, Blanton RA, Shows D, Peschon JJ, Black RA (2000) Functional analysis of the domain structure of tumor necrosis factor-alpha converting enzyme. J Biol Chem 275:14608-14614. (Pubitemid 30339751)
85. Toro JR, Aksentijevich I, Hull K, Dean J, Kastner DL (2000) Tumor necrosis factor receptor associated periodic syndrome: a novel syndrome with cutaneous manifestations. Arch Dermatol 136:1487-1494. (Pubitemid 32009269)
86. Gottorno M, Pelagatti MA, Meini A, Obici L, Barcellona R, Federici S, Buoncompagni A, Plebani A, Merlini G, Martini A (2008) Persistent efficacy of anakinra in patients with tumor necrosis factor receptor associated periodic syndrome. Arthritis Rheum 58:1516-1520. (Pubitemid 351705941)
87. Akpolat T, Akkoyunlu M, Akpolat I, Dilek M, Odabas AR, Ozen S (2002) Renal Behçet's disease: a cumulative analysis. Semin Arthritis Rheum 31:317-337. (Pubitemid 34415257)
88. Penza R, Brunetti L, Francioso G, Tricarico A, Lospalluti M (1983) Renal amyloidosis in a child with Behçet's syndrome. Int J Pediatr Nephrol 4:35-37. (Pubitemid 13057112)
89. Kaltenis P, Mudeniené V, Maknavicius S, Seinin D (2008) Renal amyloidosis in a child with chronic granulomatous disease and invasive aspergillosis. Pediatr Nephrol 23:831-834.
90. Simşek B, Bayazit AK, Ergin M, Soran M, Dursun H, Kilinc Y (2006) Renal amyloidosis in a child with sickle cell anemia. Pediatr Nephrol 21:877-879. (Pubitemid 43740961)
91. Büyükpamukçu M, Hazar V, Tinaztepe K, Bakkaloglu A, Akyüz C, Kutluk T (2000) Hodgkin's disease and renal paraneoplastic syndromes in childhood. Turk J Pediatr 42:109-114.
92. Kyle RA, Rajkumar SV (2007) Epidemiology of the plasma-cell disorders. Best Pract Res Clin Haematol 20:637-664. (Pubitemid 350215374)
93. Mor A, Pillinger MH, Kishimoto M, Abeles AM, Livneh A (2007) Familial Mediterranean fever successfully treated with etanercept. J Clin Rheumatol 13:38-40. (Pubitemid 46213843)
94. Gottenberg JE, Merle-Vincent F, Bentaberry F, Allanore Y, Berenbaum F, Fautrel B, Combe B, Durbach A, Sibilia J, Dougados M, Mariette X (2003) Anti-tumor necrosis factor alpha therapy in fifteen patients with AA amyloidoses secondary to inflammatory arthritis. Arthritis Rheum 48:2019-2024. (Pubitemid 36828697)
95. Ozen S, Bilginer Y, Ayaz NA, Calguneri M (2010) Anti IL1 treatment for FMF patients resistant to colchicines: reasoning treatment from laboratory experience. J Rheumatol. doi:10.3899/jrheumatol.100718.
96. Bilginer Y, Ayaz NA, Ozen S (2009) Anti-IL-1 treatment for secondary amyloidosis in an adolescent with FMF and Behçet's disease. Clin Rheumatol 29:209-210.
97. Dember LM (2009) Modern treatment of amyloidosis: unresolved questions. J Am Soc Nephrol 20:469-472.
98. Sekijima Y, Kelly JW, Ikeda S (2008) Pathogenesis of and therapeutic strategies to ameliorate the transthyretin amyloidoses. Curr Pharm Des 14:3219-3230.
99. Dember LM, Hawkins PN, Hazenberg BP, Gorevic PD, Merlini G, Butrimiene I, Livneh A, Lesnyak O, Puéchal X, Lachmann HJ, Obici L, Balshaw R, Garceau D, Hauck W, Skinner M (2007) Eprodisate for AA Amyloidosis Trial Group. Eprodisate for the treatment of renal disease in AA amyloidosis. N Engl J Med 356:2349-2360. (Pubitemid 46883769)
100. Rysavá R, Merta M, Spicka I, Tesar V (2003) Current therapeutic possibilities in primary and secondary amyloidosis and our experience with 31 patients. Nephrol Dial Transplant 18(Suppl 5):v38-v40. (Pubitemid 36896449)
101. Keven K, Sengul S, Kutlay S, Ekmekci Y, Anadol E, Nergizoglu G, Ates K, Erturk S, Erbay B (2004) Long-term outcome of renaltransplantation in patients with familial Mediterranean fever amyloidosis: a single-center experience. Transplant Proc 36:2632-2634. (Pubitemid 40036797)
102. Altiparmak MR, Pamuk ON, Ataman R, Serdengeçti K (2004) Continuous ambulatory peritoneal dialysis in familial Mediterranean fever amyloidosis patients with end-stage renal failure: a single-centre experience from Turkey. Nephron Clin Pract 98: c119-c123. (Pubitemid 40069643)
103. Ari JB, Zlotnik M, Oren A, Berlyne GM (1976) Dialysis in renal failure caused by amyloidosis of familial Mediterranean fever. A report of ten cases. Arch Intern Med 136:449-451.
104. Sahin S, Sahin GM, Ergin H, Kantarci G (2007) The effect of dialytic modalities on clinical outcomes in ESRD patients with familial Mediterranean fever. Ren Fail 29:315-319. (Pubitemid 46752351)
105. Tan SY, Irish A, Winearls CG, Brown EA, Gower PE, Clutterbuck EJ, Madhoo S, Lavender JP, PepysMB, Hawkins PN (1996) Longterm effect of renal transplantation on dialysis-related amyloid deposits and symptomatology. Kidney Int 50:282-289. (Pubitemid 26323724)
106. Gillmore JD, Lachmann HJ, Rowczenio D, Gilbertson JA, Zeng CH, Liu ZH, Li LS, Wechalekar A, Hawkins PN (2009) Diagnosis, pathogenesis, treatment, and prognosis of hereditary fibrinogen A alpha-chain amyloidosis. J Am Soc Nephrol 20:444-451.
107. Saglam F, Celik A, Cavdar C, Sifil A, Atila K, Kaya GC, Bora S, Gulay H, Camsari T (2008) A renal transplant recipient with delayed gastric emptying in amyloidosis due to familial Mediterranean fever improved with erythromycin: a case report. Transplant Proc 40:308-309. (Pubitemid 351186613)
108. Terkeltaub RA (2009) Colchicine update: 2008. Semin Arthritis Rheum 38:411-419.
109. Tweezer-Zaks N, Rabinovich E, Lidar M, Livneh A (2008) Interferon-alpha as a treatment modality for colchicine-resistant familial Mediterranean fever. J Rheumatol 35:1362-1365. (Pubitemid 352000785)
110. Fabrizi F, Messa P, Basile C, Martin P (2010) Hepatic disorders in chronic kidney disease. Nat Rev Nephrol 6:395-403.
111. Moser C, Pohl G, Haslinger I, Knapp S, Rowczenio D, Russel T, Lachmann HJ, Lang U, Kovarik J (2009) Successful treatment of familial Mediterranean fever with Anakinra and outcome after renal transplantation. Nephrol Dial Transplant 24:676-678.